Weight Loss Peptides in Thailand

Weight loss peptides such as AOD-9604, Tesamorelin, and MOTS-c have been studied for their effects on fat metabolism and body composition. Learn about physician-supervised peptide therapy in Thailand.

Unlike many conventional weight loss approaches, these peptides may work by modulating specific metabolic pathways rather than simply suppressing appetite.

At Peptides Thailand, our physicians take an evidence-based approach to weight management peptide therapy, prescribing clinical-grade compounds prepared by licensed Thai compounding pharmacies with COA verification.

How Peptides May Support Weight Management

The body’s weight regulation system involves complex interactions between hormones, metabolic enzymes, fat tissue biology, and energy expenditure. Weight loss peptides that have been studied in research settings generally target one or more of these pathways:

• Growth hormone modulation: Several peptides influence the growth hormone axis, which plays a role in fat metabolism, lean body mass maintenance, and metabolic rate
• Direct lipolysis: Some peptides may directly stimulate the breakdown of stored fat through activation of lipolytic pathways
• Mitochondrial function: Peptides like MOTS-c may support cellular energy metabolism, potentially improving how the body processes nutrients
• Insulin sensitivity: Improved insulin signaling may support healthier body composition by promoting more efficient nutrient partitioning

Key Weight Loss Peptides

AOD-9604

AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191). It was originally developed as a potential anti-obesity treatment and has been the subject of clinical trials evaluating its effects on fat loss.

Mechanism of action: AOD-9604 may stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) through pathways similar to growth hormone, but without the broader metabolic effects that can accompany full-length growth hormone therapy. For a detailed comparison with another fat-targeting peptide, see our Tesamorelin vs AOD-9604 page.

Research highlights:

• Clinical trials in Australia evaluated AOD-9604 for weight loss in obese patients
• The peptide received GRAS (Generally Recognized As Safe) status for use as a food ingredient, indicating a favorable safety assessment
• Research suggests it may promote fat loss without the insulin resistance, glucose intolerance, or growth-promoting effects associated with growth hormone

Clinical application: AOD-9604 is typically administered via subcutaneous injection, often in the abdominal area. Treatment protocols generally span 12 to 24 weeks.

Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been extensively studied in clinical trials for HIV-associated lipodystrophy. It represents one of the most well-studied peptides in the context of fat reduction.

Mechanism of action: Tesamorelin stimulates the pituitary gland to release growth hormone in a physiological, pulsatile manner. The resulting increase in growth hormone may promote visceral fat reduction while preserving lean body mass. Because it works through the body’s own regulatory feedback loops, it may produce more physiological growth hormone patterns than exogenous growth hormone administration.

Research highlights:

• Randomized controlled trials demonstrated significant reduction in visceral adipose tissue in HIV patients with lipodystrophy
• Studies suggest improvements in triglyceride levels and trunk fat in treated patients
• Research indicates the effects are specific to visceral fat, with limited impact on subcutaneous fat

Clinical application: Tesamorelin is administered via subcutaneous injection, typically as a daily injection. Our physicians may prescribe it for patients with excess visceral fat or metabolic concerns.

MOTS-c

MOTS-c is a mitochondria-derived peptide that has emerged as a significant area of research in metabolic health. As a mitochondrial signaling peptide, it connects cellular energy production with whole-body metabolic regulation.

Mechanism of action: MOTS-c may influence metabolism through activation of AMPK (AMP-activated protein kinase), a key energy sensor that regulates glucose and fat metabolism. Research suggests it may also play a role in exercise-mimetic effects, potentially enhancing cellular metabolic function.

Research highlights:

• Animal studies have shown MOTS-c may prevent diet-induced obesity and improve insulin sensitivity
• Research suggests MOTS-c levels decline with age, potentially contributing to age-related metabolic dysfunction
• Studies indicate MOTS-c may enhance exercise capacity and metabolic adaptation

Clinical application: MOTS-c is administered via subcutaneous injection. It is often considered for patients interested in metabolic optimization alongside lifestyle modifications.

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates growth hormone release without significantly affecting cortisol or prolactin levels. Its selectivity makes it one of the better-tolerated peptides in this category.

Mechanism of action: Ipamorelin binds to ghrelin receptors in the pituitary gland, stimulating growth hormone release. The growth hormone increase may support fat metabolism and lean body mass maintenance. It is often combined with CJC-1295 for enhanced and sustained growth hormone release. See our CJC-1295 vs Ipamorelin comparison for details.

Research highlights:

• Studies suggest Ipamorelin promotes growth hormone release with minimal effect on appetite-related hormones
• Research indicates a favorable safety profile compared to other growth hormone secretagogues
• Animal studies suggest potential benefits for bone density and body composition

Supporting Peptides for Weight Management

Several other peptides may complement primary weight loss protocols:

• CJC-1295: A GHRH analogue often combined with Ipamorelin for sustained growth hormone elevation
• MK-677: An oral growth hormone secretagogue that may be convenient for patients who prefer non-injection delivery
• Tesofensine: A triple monoamine reuptake inhibitor that has been studied for weight loss through appetite modulation
• GW1516: A PPAR-delta agonist studied for its effects on fat oxidation and endurance

The Role of Medical Supervision

Weight management with peptides should always be approached as part of a comprehensive strategy that includes nutrition, physical activity, and medical oversight. Peptides are not a replacement for healthy lifestyle practices but may support patients who have reached a plateau or who have specific metabolic concerns.

Our physicians conduct thorough assessments before prescribing weight management peptides, including evaluation of metabolic markers, body composition analysis, and discussion of treatment goals and expectations.

Related Pages

• Fat Loss condition page for an in-depth look at peptide research for fat reduction
• Muscle Growth Peptides for peptides that may support lean body mass
• Hormone Peptides for peptides that influence the growth hormone axis
• Anti-Aging Peptides for peptides that address age-related metabolic changes